Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
4.580
-0.060 (-1.29%)
At close: Jan 16, 2026, 4:00 PM EST
4.600
+0.020 (0.44%)
After-hours: Jan 16, 2026, 7:54 PM EST
Immuneering Market Cap
Immuneering has a market cap or net worth of $295.73 million as of January 16, 2026. Its market cap has increased by 332.92% in one year.
Market Cap
295.73M
Enterprise Value
72.08M
1-Year Change
332.92%
Ranking
Category
Stock Price
$4.58
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $295.73M, a decrease of -19.16%. That is a compound annual growth rate of -4.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 295.73M | -30.40% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |